Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is MRK A Good Stock To Buy Right Now?’

Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug

Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc. (NYSE:MRK) claiming that its shingles vaccine, Zostavax......(read more)

March 16 - News, Stock Analysis - Comments

FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)

The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE......(read more)

March 8 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks

Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis......(read more)

February 24 - News, Stock Analysis - Comments

Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment

Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers......(read more)

February 21 - News, Stock Analysis - Comments

The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer

Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA......(read more)

February 7 - News, Stock Analysis - Comments

The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co., Inc. (MRK)

The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK). The Committee for Medicinal......(read more)

February 1 - News, Stock Analysis - Comments

trump, donald, 2014, d.c., politics, washington, politician, political, conservative, conference, cpac, republican, action

Pharmaceutical Executives From Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ) Met Trump

United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher......(read more)

February 1 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes

Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes......(read more)

January 30 - News, Stock Analysis - Comments

biotech research company, bio-technology companies

Bristol-Myers Squibb Co (BMY) To Share In Sales Of Merck & Co., Inc. (MRK) Keytruda Following Litigation Settlement

Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd......(read more)

January 24 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact

Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a......(read more)

January 18 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program

Merck & Co., Inc. (NYSE:MRK), which is popularly known as MSD outside the United States and Canada, has become part of the Oncology Research Information......(read more)

January 6 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) Gets Coveted Approval For Keytruda

Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK). The news comes......(read more)

December 2 - News, Stock Analysis - Comments

Here’s What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why It’s So Important

OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical......(read more)

November 17 - News, Stock Analysis - Comments

FDA Approves Merck & Co., Inc. (MRK) Keytruda For NSCLC

The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc. (NYSE......(read more)

October 26 - News, Stock Analysis - Comments

Merck & Co. Inc. (MRK) Shuts Down Florida Facility

Merck & Co., Inc. (NYSE:MRK) will start laying off more than 100 employees in its production plant in Florida next month as it prepares for the closure......(read more)

October 6 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Introduction Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing......(read more)

August 29 - News, Stock Analysis - Comments

mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK)

On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc. (NYSE:MRK) monoclonal......(read more)

July 22 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape

Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually......(read more)

July 19 - News, Stock Analysis - Comments

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362......(read more)

June 22 - News, Stock Analysis - Comments